Artículo
Repeated cocaine administration induces behavioral sensitization in about 50 % of treated animals. Nitric oxide could be involved in the acquisition and maintenance of behavioral cocaine effects, probably by activation of neuronal nitric oxide synthase (nNOS)/NO/soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) signaling pathway, since inhibition of the nNOS enzyme attenuates development of sensitization in rats. On the other hand, increased cGMP availability by phosphodiesterase 5 inhibitors has been correlated to the misuse and recreational use of these agents and also to the concomitant use with illicit drugs in humans. Hippocampus is an important brain region for conditioning to general context previously associated to drug availability, influencing drug-seeking behavior and sensitization. Moreover, cocaine and other drugs of abuse can affect the strength of glutamate synapses in this structure, lastly modifying neuronal activity in main regions of the reward circuitry. Repeated cocaine administration induces behavioral sensitization in about 50 % of treated animals. Nitric oxide could be involved in the acquisition and maintenance of behavioral cocaine effects, probably by activation of neuronal nitric oxide synthase (nNOS)/NO/soluble guanylyl cyclase (sGC)/cyclic guanosine monophosphate (cGMP) signaling pathway, since inhibition of the nNOS enzyme attenuates development of sensitization in rats. On the other hand, increased cGMP availability by phosphodiesterase 5 inhibitors has been correlated to the misuse and recreational use of these agents and also to the concomitant use with illicit drugs in humans. Hippocampus is an important brain region for conditioning to general context previously associated to drug availability, influencing drug-seeking behavior and sensitization. Moreover, cocaine and other drugs of abuse can affect the strength of glutamate synapses in this structure, lastly modifying neuronal activity in main regions of the reward circuitry.
Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?
Título:
Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?
Gabach, Laura
; Gabach, Laura
; Carlini, Valeria Paola
; Carlini, Valeria Paola
; Monti, María Carolina
; Monti, María Carolina
; Maglio, Laura E.; Maglio, Laura E.; Rubiales, Susana Elizabeth
; Rubiales, Susana Elizabeth
; Perez, Mariela Fernanda
; Perez, Mariela Fernanda
Fecha de publicación:
04/2013
04/2013
04/2013
Editorial:
Springer
Springer
Springer
Revista:
Psychopharmacology
Psychopharmacology
Psychopharmacology
ISSN:
0033-3158
0033-3158
0033-3158
e-ISSN:
1432-2072
1432-2072
1432-2072
Idioma:
Inglés
Inglés
Inglés
Tipo de recurso:
Artículo publicado
Clasificación temática:
Resumen
Archivos asociados
Licencia
Identificadores
Colecciones
Articulos(IFEC)
Articulos de INST. DE FARMACOLOGIA EXPERIMENTAL DE CORDOBA
Articulos de INST. DE FARMACOLOGIA EXPERIMENTAL DE CORDOBA
Citación
Gabach, Laura; Carlini, Valeria Paola; Monti, María Carolina; Maglio, Laura E.; Rubiales, Susana Elizabeth; et al.; Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?; Springer; Psychopharmacology; 229; 1; 4-2013; 41-50
Gabach, Laura; Carlini, Valeria Paola; Monti, María Carolina; Maglio, Laura E.; Rubiales, Susana Elizabeth; et al.; Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?; Springer; Psychopharmacology; 229; 1; 4-2013; 41-50
Gabach, Laura; Carlini, Valeria Paola; Monti, María Carolina; Maglio, Laura E.; Rubiales, Susana Elizabeth; et al.; Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?; Springer; Psychopharmacology; 229; 1; 4-2013; 41-50
Compartir
Altmétricas